Chick Chorioallantoic Membrane Model and Precision Cancer Therapy, Volume 46 in The Enzymes series, highlights new advances in the field, with this new volume presenting interesting chapters on the history of CAM model development, an overview of various CAM-based cancer models, the chick embryo chorioallantoic membrane as an in vivo experimental model to study multiple myelomak, bioluminescent CAM models for screening drugs against pancreatic cancer, X-ray sensitizer screen, patient derived tumor model for esophageal cancer, renal cancer and metastasis, nanoparticle characterization and tumor targeting, and patient derived tumor model for human nasopharyngeal carcinoma.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. ix 6. Preface - p. xiii 7. Chapter One: Recent excitements in the study of the CAM assay - p. xiii 8. Chapter Two: The history of the development of chick embryo tumor xenograft models - p. 9 9. Chapter Three: The chick embryo chorioallantoic membrane as an in vivo experimental model to study multiple myeloma - p. 22 10. Chapter Four: Various CAM tumor models - p. 35 11. Chapter Five: Mouse- and patient-derived CAM xenografts for studying metastatic renal cell carcinoma - p. 57 12. Chapter Six: Patient-derived tumor models for human nasopharyngeal carcinoma - p. 80 13. Chapter Seven: Patient-derived tumor models of esophageal cancer - p. 96 14. Chapter Eight: In vivo drug screening method of radiosensitizers using tumor-bearing chick embryo - p. 111 15. Chapter Nine: Nanoparticles characterization using the CAM assay - p. 127
Chick Chorioallantoic Membrane Model and Precision Cancer Therapy, Volume 46 in The Enzymes series, highlights new advances in the field, with this new volume presenting interesting chapters on the history of CAM model development, an overview of various CAM-based cancer models, the chick embryo chorioallantoic membrane as an in vivo experimental model to study multiple myelomak, bioluminescent CAM models for screening drugs against pancreatic cancer, X-ray sensitizer screen, patient derived tumor model for esophageal cancer, renal cancer and metastasis, nanoparticle characterization and tumor targeting, and patient derived tumor model for human nasopharyngeal carcinoma.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. ix 6. Preface - p. xiii 7. Chapter One: Recent excitements in the study of the CAM assay - p. xiii 8. Chapter Two: The history of the development of chick embryo tumor xenograft models - p. 9 9. Chapter Three: The chick embryo chorioallantoic membrane as an in vivo experimental model to study multiple myeloma - p. 22 10. Chapter Four: Various CAM tumor models - p. 35 11. Chapter Five: Mouse- and patient-derived CAM xenografts for studying metastatic renal cell carcinoma - p. 57 12. Chapter Six: Patient-derived tumor models for human nasopharyngeal carcinoma - p. 80 13. Chapter Seven: Patient-derived tumor models of esophageal cancer - p. 96 14. Chapter Eight: In vivo drug screening method of radiosensitizers using tumor-bearing chick embryo - p. 111 15. Chapter Nine: Nanoparticles characterization using the CAM assay - p. 127
